English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52937773    在线人数 :  511
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"kuo s h"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 111-135 / 1327 (共54页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2022-03-25T02:05:42Z Whether adjuvant radiotherapy is desired for postmastectomy patients with T1�VT2 tumors and 1�V3 positive axillary lymph nodes who received modern systemic therapy? SHIH-FAN LAI; Huang C.-S.; Kuo S.-H.
臺大學術典藏 2022-03-15T05:39:28Z High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country Lin C.-H.; Shen C.-Y.; Lee J.-H.; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; WEI-WU CHEN; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L.
臺大學術典藏 2022-03-10T02:31:38Z Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer PO-HAN LIN; Kuo W.-H.; Huang A.-C.; Lu Y.-S.; Lin C.-H.; Kuo S.-H.; Wang M.-Y.; Liu C.-Y.; Cheng F.T.-F.; Yeh M.-H.; Li H.-Y.; Yang Y.-H.; Hsu Y.-H.; Fan S.-C.; Li L.-Y.; Yu S.-L.; Chang K.-J.; Chen P.-L.; Ni Y.-H.; Huang C.-S.
臺大學術典藏 2022-03-10T02:31:37Z Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer Kuo S.-H.; Yang S.-Y.; You S.-L.; Lien H.-C.; Lin C.-H.; PO-HAN LIN; Huang C.-S.
臺大學術典藏 2022-03-10T02:31:35Z Using next-generation sequencing to redefine BRCAness in triple-negative breast cancer PO-HAN LIN; Chen M.; Tsai L.-W.; Lo C.; Yen T.-C.; Huang T.Y.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S.
臺大學術典藏 2022-03-10T02:31:34Z Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy PO-HAN LIN; Wang M.-Y.; Lo C.; Tsai L.-W.; Yen T.-C.; Huang T.Y.; Huang W.-C.; Yang K.; Chen C.-K.; Fan S.-C.; Kuo S.-H.; Huang C.-S.
臺大學術典藏 2022-03-08T03:44:08Z Gemcitabine-based combination chemotherapy as salvage treatment for refractory or relapsing aggressive non-Hodgkin's lymphoma SHIH-HUNG YANG; Lin Z.-Z.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏 2022-03-08T03:44:08Z Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [2] SHIH-HUNG YANG; Kuo S.-H.
臺大學術典藏 2022-03-08T03:44:07Z Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphoma SHIH-HUNG YANG; Lin L.-W.; Fang Y.-J.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2022-03-08T03:44:07Z Inferior survival of advanced pancreatic cancer patients who received gemcitabine-based chemotherapy but did not participate in clinical trials SHIH-HUNG YANG; Kuo Y.-H.; Tien Y.-W.; Hsu C.; Hsu C.-H.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏 2022-03-08T03:44:06Z Nuclear expression of glioma-associated oncogene homolog 1 and nuclear factor-�eb is associated with a poor prognosis of pancreatic cancer SHIH-HUNG YANG; Hsu C.-H.; Lee J.-C.; Tien Y.-W.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏 2022-03-08T03:44:05Z Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer SHIH-HUNG YANG; Kuo T.-C.; Wu H.; Guo J.-C.; Hsu C.; Hsu C.-H.; Tien Y.-W.; Yeh K.-H.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2022-03-08T03:44:04Z Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy SHIH-HUNG YANG; Lee J.-C.; Guo J.-C.; Kuo S.-H.; Tien Y.-W.; Kuo T.-C.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2022-03-08T03:44:04Z Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer SHIH-HUNG YANG; Guo J.-C.; Yeh K.-H.; Tien Y.-W.; Cheng A.-L.; Kuo S.-H.
臺大學術典藏 2022-03-08T03:44:03Z Postoperative imaging and tumor marker surveillance in resected pancreatic cancer Wu H.; Guo J.-C.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H.
臺大學術典藏 2022-03-08T03:44:03Z A Phase i study of S-1-based concurrent chemoradiotherapy followed by gemcitabine and S-1 in metastatic pancreatic adenocarcinoma SHIH-HUNG YANG; Shao Y.-Y.; Lin C.-C.; Kuo S.-H.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2022-03-08T03:44:02Z S-1�Vassociated hypertriglyceridemia in a patient with pancreatic adenocarcinoma Chen H.-W.; Kuo H.-Y.; Chen B.-B.; Tien Y.-W.; Kuo S.-H.; SHIH-HUNG YANG
臺大學術典藏 2022-03-08T03:44:02Z Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients SHIH-HUNG YANG; Guo J.-C.; Hsu C.; Kuo S.-H.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2022-03-08T03:44:01Z Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma SHIH-HUNG YANG; Lu L.-C.; Kao H.-F.; Chen B.-B.; Kuo T.-C.; Kuo S.-H.; Tien Y.-W.; Bai L.-Y.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2022-03-08T03:43:59Z Contribution of nuclear BCL10 expression to tumor progression and poor prognosis of advanced and/or metastatic pancreatic ductal adenocarcinoma by activating NF-�eB-related signaling Kuo S.-H.; SHIH-HUNG YANG; Wei M.-F.; Lee H.-W.; Tien Y.-W.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2022-03-08T03:43:58Z Competing Risk Analysis of Outcomes of Unresectable Pancreatic Cancer Patients Undergoing Definitive Radiotherapy Chen Y.-L.; Tsai C.-L.; Cheng J.C.-H.; Wang C.-W.; SHIH-HUNG YANG; Tien Y.-W.; Kuo S.-H.
臺大學術典藏 2022-03-04T05:33:29Z Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer Chen W.-Y.; CHEN-TU WU; Wang C.-W.; Lan K.-H.; Liang H.-K.; Huang B.-S.; Chang Y.-L.; Kuo S.-H.; Cheng A.-L.
臺大學術典藏 2022-02-22T03:37:23Z Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trial Liou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Fang Y.-J.; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; PING-HUEI TSENG; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.
臺大學術典藏 2022-02-21T03:52:43Z Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: The molecular mechanism and the clinical application JIH-HSIANG LEE; Cheng A.-L.; Lin C.-W.; Kuo S.-H.
臺大學術典藏 2022-02-21T03:52:38Z High prevalence of the BIM deletion polymorphism in young female breast cancer in an East Asian country Lin C.-H.; Shen C.-Y.; JIH-HSIANG LEE; Huang C.-S.; Yang C.-H.; Kuo W.-H.; Chang D.-Y.; Hsiung C.-N.; Kuo K.-T.; Chen W.-W.; Chen I.-C.; Wu P.-F.; Kuo S.-H.; Chen C.-J.; Lu Y.-S.; Cheng A.-L.

显示项目 111-135 / 1327 (共54页)
<< < 1 2 3 4 5 6 7 8 9 10 > >>
每页显示[10|25|50]项目